Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate

Author： Akakura K.   Akimoto S.   Ohki T.   Shimazaki J.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.45, Iss.4, 1995-04, pp. : 700-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiandrogen withdrawal syndrome with nilutamide

By Huan S.D.   Gerridzen R.G.   Yau J.C.   Stewart D.J.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 632-634

Elsevier

Access to resources Recommend Favorite

Prostate cancer risk after anti-androgen treatment for priapism

By Goetz Tabitha   Burnett Arthur  

International Urology and Nephrology, Vol. 46, Iss. 4, 2014-04 ,pp. : 757-760

Springer Publishing Company

Access to resources Recommend Favorite

Antiandrogen withdrawal syndrome with cyproterone acetate - effect of prior hormonal therapy

By Sella A.   Flex D.   Sulkes A.   Baniel J.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1091-1093

Elsevier

Access to resources Recommend Favorite

Hormone-refractory Prostate Cancer? Anti-androgen Withdrawal and Intermittent Hormone Therapy

By Sciarra Alessandro   Casale Paolo   Colella Dario   Chiro Costantino Di   Silverio Franco Di  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 4, 1999-09 ,pp. : 211-216

Informa Healthcare

Access to resources Recommend Favorite

Suramin treatment in hormone- and chemotherapy-refractory prostate cancer - anti-androgen treated patients

By Garcia-Schurmann J.M.   Schulze H.   Haupt G.   Pastor J.   Allolio B.   Senge T.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 535-541

Elsevier

Access to resources Recommend Favorite